GENE ONLINE|News &
Opinion
Blog

FDA
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
Gilead’s Viral Hepatitis Treatment Scores a Win in Pivotal Study
2022-06-24
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
Eli Lilly Nabs FDA Approval For First-Ever Systemic Treatment Targeting Alopecia Areata
2022-06-14
FDA Panel Recommends Novavax To Be Fourth Authorized COVID-19 Vaccine in America
2022-06-08
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
FDA Approves GSK’s MMR Vaccine Amidst Rise in Missed Vaccinations Among Children
2022-06-07
Sanofi and Sobi Receive Breakthrough Therapy Designation for Hemophilia A Drug
2022-06-02
The FDA is Investigating a Hepatitis A Outbreak Linked to Strawberries in the United States and Canada
2022-05-31
Sanofi’s Trial to Make Cialis Available Over-the-Counter Meets FDA Hold
2022-05-31
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
1 2 3 19
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
2022-07-03
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top